Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Cardinal Health Rose as Much as 13.7% Today

By Maxx Chatsko - Feb 6, 2020 at 1:37PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The healthcare company reported solid quarterly earnings and raised its fiscal full-year 2020 guidance.

What happened

Shares of Cardinal Health (CAH -1.68%) gained over 11% today after the healthcare company reported solid fiscal second-quarter 2020 operating results and raised its fiscal full-year 2020 guidance. 

The business reported quarterly revenue growth of 5% compared to the year-ago period. Cardinal Health received a significant earnings boost from its generic pharmaceuticals portfolio, which is surprising considering generic drugs have presented challenges to many companies across the industry due to increased competition, lower selling prices, and mounting legal issues. 

As of 1:12 p.m. EST, the pharma stock had settled to a 12.1% gain.

A stethoscope on a blue surface.

Image source: Getty Images.

So what

Cardinal Health reports two segments: pharmaceutical and medical. In the fiscal second quarter of 2020, the pharmaceutical business generated revenue of $35.7 billion and income of $462 million, while the medical segment reported revenue of $4 billion and income of $195 million. 

The company reported total revenue of $39.7 billion and adjusted earnings per share (EPS) of $1.52. Both quarterly totals beat Wall Street's expectations for $39.4 billion in sales and $1.22 in adjusted EPS, according to numbers compiled by Yahoo! Finance. 

While Cardinal Health reported a 34% decrease in quarterly operating income compared to the year-ago period, investors didn't seem to mind. Instead, they seem pleased that management raised fiscal full-year 2020 guidance for adjusted EPS to a midpoint of $5.30, up from a previous midpoint of $4.97. 

Now what

Shares of Cardinal Health have surged in recent months since bottoming out in late 2019. Although there's plenty of ground to make up before the stock can threaten its 10-year peak of about $90 per share, investors are cautiously optimistic that the business is heading in the right direction.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cardinal Health, Inc. Stock Quote
Cardinal Health, Inc.
$54.89 (-1.68%) $0.94

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.